The end of the hypoxic EPOch

Int J Radiat Oncol Biol Phys. 2015 Apr 1;91(5):895-7. doi: 10.1016/j.ijrobp.2015.01.041.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Anemia / complications
  • Anemia / therapy
  • Blood Transfusion
  • Carcinoma, Squamous Cell / radiotherapy*
  • Cell Hypoxia / drug effects*
  • Cell Hypoxia / physiology
  • Clinical Trials as Topic
  • Erythropoietin / adverse effects*
  • Etanidazole / therapeutic use
  • Female
  • Head and Neck Neoplasms / radiotherapy*
  • Humans
  • Male
  • Misonidazole / therapeutic use
  • Radiation-Sensitizing Agents / adverse effects*
  • Radiation-Sensitizing Agents / therapeutic use
  • Receptors, Erythropoietin / metabolism
  • Treatment Failure
  • Uterine Cervical Neoplasms / radiotherapy*

Substances

  • Radiation-Sensitizing Agents
  • Receptors, Erythropoietin
  • Erythropoietin
  • Etanidazole
  • Misonidazole